The Cancers That Hide in Plain Sight: Early Detection Guide for Gastric, Pancreatic & Liver Cancer

The Cancers That Hide in Plain Sight: Early Detection Guide for Gastric, Pancreatic & Liver Cancer

Real Cases: What Late-Stage Diagnosis Looks Like

Three cases from our Patient Success Stories illustrate both the danger and the hope surrounding abdominal cancers.

A 72-year-old man arrived at Renji Hospital with advanced gastric cancer. Through conversion chemotherapy followed by minimally invasive gastrectomy performed by Professor Hui Cao, he achieved remission and returned to peaceful senior life in Shanghai. A 78-year-old woman with pancreatic head cancer - one of the most feared diagnoses in oncology - underwent a minimally invasive Whipple procedure at Fudan University Shanghai Cancer Center under Professor Xianjun Yu and made a remarkable recovery. A young father with massive liver cancer underwent a complex two-stage surgical plan at Zhongshan Hospital under Dr. Jian Zhou, ultimately having the tumor removed after allowing his liver to regenerate.

These outcomes are extraordinary. But they share a sobering reality: all three patients were diagnosed at an advanced stage. Had these cancers been detected earlier, treatment would have been simpler, less risky, and far more likely to result in a cure.


Why These Three Cancers Are Particularly Dangerous

Gastric, pancreatic, and liver cancers are grouped together here for a critical reason: they are all notorious for producing few or no symptoms in their early stages, when treatment is most effective. By the time symptoms appear, the cancer has often already spread.

  • Gastric cancer (stomach cancer) - 5th most common cancer worldwide. Early-stage gastric cancer is highly curable (90%+ 5-year survival), but most cases in Western countries are diagnosed at late stage (20-30% 5-year survival).
  • Pancreatic cancer - Often called the king of cancers due to its poor prognosis. Overall 5-year survival is around 12%, but for stage I disease caught early, it rises to over 80%.
  • Liver cancer (hepatocellular carcinoma) - 6th most common cancer globally and 3rd leading cause of cancer death. Early-stage liver cancer is highly treatable with surgery, ablation, or transplant. Late-stage disease has very limited options.

The common thread: early detection is the single most powerful tool we have against all three.


Gastric Cancer: Risk Factors, Symptoms & Screening

Who Is at Risk

  • H. pylori infection - the most important modifiable risk factor. This bacterial infection is present in over 50% of the world's population and dramatically increases gastric cancer risk.
  • Diet high in smoked, salted, or pickled foods and low in fresh fruits and vegetables
  • Smoking - doubles the risk of gastric cancer
  • Family history of gastric cancer or hereditary syndromes (Lynch syndrome, FAP)
  • Previous stomach surgery or chronic atrophic gastritis
  • Age over 50, male sex, East Asian ethnicity (China, Japan, Korea have the highest rates globally)

Warning Signs (Often Absent Until Late Stage)

  • Persistent indigestion, heartburn, or upper abdominal discomfort
  • Feeling full quickly after eating small amounts (early satiety)
  • Unexplained weight loss
  • Nausea or vomiting, especially after meals
  • Black or tarry stools (indicating bleeding in the stomach)
  • Difficulty swallowing (if cancer is near the gastroesophageal junction)
  • Fatigue and anemia (from chronic blood loss)

Screening Recommendations

  • H. pylori test and treat: All adults should be tested for H. pylori infection. If positive, eradication therapy (a short course of antibiotics) significantly reduces gastric cancer risk. This is one of the most cost-effective cancer prevention interventions available.
  • Gastroscopy (upper endoscopy): Recommended every 1-2 years for high-risk individuals (age 45+, H. pylori history, family history, atrophic gastritis). In Japan and South Korea, population-wide gastroscopy screening has dramatically reduced gastric cancer mortality - a model worth following.
  • Blood tests: Pepsinogen I/II ratio and gastrin-17 can identify atrophic gastritis (a precancerous condition) non-invasively.

Pancreatic Cancer: Risk Factors, Symptoms & Screening

Who Is at Risk

  • Smoking - responsible for approximately 25% of pancreatic cancers
  • Type 2 diabetes or new-onset diabetes after age 50 (can be an early sign of pancreatic cancer)
  • Chronic pancreatitis - long-term inflammation of the pancreas
  • Obesity and sedentary lifestyle
  • Family history - approximately 10% of pancreatic cancers have a hereditary component (BRCA1/2, PALB2, ATM mutations)
  • Heavy alcohol consumption
  • Age over 60, male sex

Warning Signs (Typically Late-Stage)

  • Painless jaundice (yellowing of skin and eyes) - often the first sign of pancreatic head cancer, as the tumor blocks the bile duct
  • Upper abdominal pain radiating to the back, often worse when lying down and relieved by leaning forward
  • Unexplained weight loss and loss of appetite
  • New-onset diabetes in a non-obese adult over 50
  • Light-colored or greasy stools and dark urine (bile duct obstruction)
  • Nausea, vomiting, and fatigue
  • Blood clots (pancreatic cancer has a high rate of venous thromboembolism)

Screening Recommendations

  • High-risk individuals: Those with 2+ first-degree relatives with pancreatic cancer, or known genetic mutations (BRCA2, PALB2, Lynch syndrome), should undergo annual surveillance with endoscopic ultrasound (EUS) and/or MRI/MRCP starting at age 50 (or 10 years before the youngest affected relative).
  • CA 19-9 blood test: Not reliable as a standalone screening test (low sensitivity in early disease), but useful for monitoring known disease or in combination with imaging.
  • General population: No validated population-wide screening exists yet. The best prevention strategies are smoking cessation, weight management, and diabetes control.
  • New-onset diabetes surveillance: Adults over 50 with new-onset diabetes and no obvious cause (not obese, no family history of diabetes) should have pancreatic imaging to rule out underlying malignancy.

Liver Cancer: Risk Factors, Symptoms & Screening

Who Is at Risk

  • Chronic hepatitis B or C infection - the leading cause of liver cancer worldwide. Hepatitis B vaccination and antiviral treatment dramatically reduce risk.
  • Liver cirrhosis from any cause (alcohol, fatty liver disease, autoimmune hepatitis)
  • Non-alcoholic fatty liver disease (NAFLD) / metabolic-associated fatty liver disease (MAFLD) - rapidly increasing in prevalence due to obesity and diabetes
  • Heavy alcohol consumption
  • Aflatoxin exposure (a mold toxin found in improperly stored grains and nuts, more relevant in certain regions)
  • Type 2 diabetes and obesity
  • Family history of liver cancer
  • Male sex, age over 40

Warning Signs (Often Absent Until Advanced Stage)

  • Right upper abdominal pain or discomfort
  • Abdominal swelling or a palpable mass
  • Unexplained weight loss and loss of appetite
  • Jaundice (yellowing of skin and eyes)
  • Fatigue and weakness
  • Nausea and vomiting
  • In patients with cirrhosis: sudden deterioration of liver function

Screening Recommendations

  • High-risk individuals (cirrhosis, chronic hepatitis B): Liver ultrasound every 6 months, with or without AFP (alpha-fetoprotein) blood test. This is the international standard of care and has been shown to detect liver cancer at an earlier, more treatable stage.
  • Hepatitis B vaccination: All unvaccinated adults should be vaccinated. This is one of the most effective cancer prevention vaccines available.
  • Hepatitis B and C testing: All adults should be tested at least once. Effective antiviral treatments now exist for both - hepatitis C can be cured in 8-12 weeks with direct-acting antivirals.
  • Fatty liver monitoring: Adults with NAFLD/MAFLD should have regular liver ultrasound and liver function tests to monitor for progression to cirrhosis.
  • AFP-L3 and PIVKA-II: More sensitive blood markers than standard AFP, increasingly used in Asia for early liver cancer detection.

Shared Prevention Strategies for All Three Cancers

While each cancer has specific risk factors, several lifestyle interventions reduce risk across all three:

  • Quit smoking: Smoking is a risk factor for gastric, pancreatic, and liver cancer. Cessation reduces risk within years.
  • Limit alcohol: Heavy drinking damages the stomach lining, causes chronic pancreatitis, and leads to liver cirrhosis - all precursors to cancer.
  • Maintain a healthy weight: Obesity is an independent risk factor for all three cancers. Even modest weight loss reduces risk.
  • Eat a protective diet: High intake of fresh fruits, vegetables, and whole grains is consistently associated with lower gastric and liver cancer risk. Reduce processed meats, smoked foods, and high-fat diets.
  • Control diabetes: Type 2 diabetes increases risk of pancreatic and liver cancer. Tight glucose control and weight management are protective.
  • Get vaccinated: Hepatitis B vaccine prevents liver cancer. H. pylori eradication prevents gastric cancer. These are among the most powerful cancer prevention tools available.

Getting Screened in Shanghai

Shanghai is one of the best places in the world to access high-quality, affordable cancer screening. Key advantages include:

  • Gastroscopy at top Shanghai hospitals: $80-$200 USD (vs. $1,500-$3,000 in the US)
  • Liver ultrasound + AFP blood test: $50-$100 USD
  • H. pylori breath test or blood test: $20-$50 USD
  • Hepatitis B/C panel: $30-$80 USD
  • Appointments typically available within days, not months

China Medical Concierge coordinates cancer screening packages at Fudan University Shanghai Cancer Center, Renji Hospital, Zhongshan Hospital, and other leading institutions - with English-speaking coordination and on-site translation throughout.

We also assist with result interpretation, specialist referrals, and second opinions if abnormalities are found.


The Bottom Line

A 78-year-old surviving pancreatic cancer. A young father's liver tumor removed. A 72-year-old beating advanced gastric cancer. These outcomes are possible - but they required extraordinary surgical skill and a degree of luck.

The better story is the one where the cancer is found at Stage I, treated with a straightforward procedure, and never becomes a life-threatening crisis. That story starts with screening.

Know your risk factors. Get tested for H. pylori and hepatitis B. Don't ignore persistent digestive symptoms. Screen early.

To arrange a cancer screening package in Shanghai, contact China Medical Concierge - we'll handle everything from booking to translation so you can focus on your health.

0 commenti

Lascia un commento